跳至主要内容
临床试验/ACTRN12624000551594
ACTRN12624000551594进行中(未招募)Unknown

Proof of concept, feasibility and acceptability of an online FODMAP intervention for adults with irritable bowel syndrome.

Monash University0 个研究点目标入组 8 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults aged 18 years or older with self-reported IBS which meets ROME IV criteria. Potential participants must be symptomatic at time of recruitment as indicated by a symptom severity score >75 measured using the IBS-SSS (IBS Symptom Severity Score)

排除标准

  • Presence or known history of other GI diseases i.e. coeliac disease or inflammatory bowel disease) or history of major GI surgery (except appendectomy or haemorrhoidectomy).
  • Presence of major comorbidities that could explain current gastrointestinal symptoms i.e. severe diabetic, cardiac, liver, neurological, neuropathy disease.
  • Alarm symptoms (e.g. blood in stool, rapid weight loss, nocturnal symptoms, recent change in bowel habits if >50 years) shown to predict presence of organic diseases.
  • Less than 2 years of IBS symptoms regardless of when diagnosis given
  • History or current diagnosis of anorexia nervosa, binge eating disorder or bulimia nervosa). Participants with avoidant/restrictive food intake disorder (ARFID) or milder forms of disordered eating may be included.
  • History or current diagnosis of psychotic disorder or bipolar disorder; current diagnosis of substance abuse disorder or major depressive disorder or active suicidal ideation.
  • Body Mass Index (BMI) < 18.5kg/m2
  • Pregnant or lactating or plans to become pregnant during study duration
  • Currently on a restriction/elimination diet for gastrointestinal symptoms (e.g. low FODMAP diet, gluten free diet) or have undertaken the 3-phase low FODMAP diet delivered by a dietitian within the last two years. Those following a lactose free diet will be eligible if they agree to keep intake consistent unless advised to reduce further.
  • Current enteral/parenteral feeding or use of supplemental feeds (e.g. Ensure)
  • Currently undertaking brain-gut behaviour therapy (e.g. gut-directed hypnotherapy; gut-directed psychotherapy; mindfulness-based stress reduction; mindfulness-based cognitive therapy). Participants engaged in regular stress reduction activities such as breathing exercises, psychology counselling, mindfulness, and/or physical activity will be encouraged to continue with these activities during the 12-week intervention program.
  • Commenced or change in dose of IBS medications (e.g. antidepressants) in the three months preceding study commencement.
  • Commenced or change in dose of antibiotics and medications that potentially affect the gastrointestinal transit (e.g. anti-diarrhoeals and laxatives) in the month preceding study commencement. Supplements such as probiotics, prebiotics, fibre supplements and digestive enzymes will be allowed, provided that participants have been on a stable dose for at least 1 month before inclusion.
  • Not willing to change current diet or dietary supplement intake (e.g. fibre supplements)
  • No access to internet or computer
  • Insufficient language or computer skills to complete a text based online treatment.
  • Inability to provide informed consent

研究者

相似试验